glp 1 retinopathy GLP-1 Drugs and Diabetic Eye Disease: Ozempic, Semaglutide, and Risk Are GLP-1 receptor agonists and
Description
The European Medicines Agency added a NAION warning to the Ozempic label that same month after reviewing safety data involving semaglutide and reported optic nerve injuries
Obesity: global epidemiology and pathogenesis
Monitoring and Follow-Up Care Regular medical supervision is essential when using GLP-1 medications, regardless of where you purchase them
10.2967/jnumed.121.262327 9 BromM.OyenW
That doesnt necessarily make them dangerous but it does mean Im trusting my health to a supply chain that barely exists
Keep them in the fridge
